For instance, in RA, Gal-9 has been shown to modulate inflammation by suppressing Th17 cell activity, a key driver of RA pathogenesis, while simultaneously supporting the expansion of Tregs and inducing apoptosis in activated T cells. The gene discussed is LGALS9; the disease is rheumatoid arthritis.